Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

Nobili, Annalisa, Latagliata, Emanuele Claudio, Viscomi, Maria Teresa, Cavallucci, Virve, Cutuli, Debora, Giacovazzo, Giacomo, Krashia, Paraskevi, Rizzo, Francesca Romana +14 more·2017·Nature Communications

Cited by (521)

Items 101–200 of 521

  1. The dopaminergic system and Alzheimer’s disease
    Yuhan Zhang, Yuan Liang, Yixue Gu · 2024 · Neural Regeneration Research
  2. Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands
    Marek Bajda, Dorota Łażewska, Justyna Godyń, Paula Zaręba, Kamil Kuder, Stefanie Hagenow, Kamil Łątka, Ewelina Stawarska, Holger Stark, Katarzyna Kieć‐Kononowicz et al. · 2019 · European Journal of Medicinal Chemistry
  3. The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
    Paraskevi Krashia, Elena Spoleti, Marcello D’Amelio · 2022 · Frontiers in Psychiatry
  4. Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases
    Amarendranath Choudhury, Tripti Sahu, Praveena L. Ramanujam, Amit Kumar Banerjee, Indrajeet Chakraborty, Arun Kumar R, Neelima Arora · 2018 · Neuropsychiatry
  5. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
    Sarah Falk, Jonas Petersen, Charlotte Svendsen, César Ramón Romero Leguizamón, Søren H. Jørgensen, Nathalie Krauth, Mette Q. Ludwig, Kathrine Lundø, Urmas Roostalu, Grethe Skovbjerg et al. · 2023 · Cell Reports
  6. Next-Generation Diamond Electrodes for Neurochemical Sensing: Challenges and Opportunities
    Erin K. Purcell, Michael Becker, Yue Guo, Seth A. Hara, Kip A. Ludwig, Collin McKinney, Elizabeth Monroe, Robert Rechenberg, Cory A. Rusinek, Akash Saxena et al. · 2021 · Micromachines
  7. Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer’s disease mouse model
    Eduardo J. Fernández-Pérez, Scarlet Gallegos, Lorena Armijo‐Weingart, Anibal Araya, Nicolás Riffo-Lepe, Francisca Cayumán, Luis Gerardo Aguayo · 2020 · Scientific Reports
  8. Copper neurotoxicity: Induction of cognitive dysfunction: A review
    Feng, Duan, Zhao, Yu, Li, Wei, Li, Xuechao, Wan, Jixiang, Wang, Fangjun · 2023 · Medicine
  9. Activation of a Locus Coeruleus to Dorsal Hippocampus Noradrenergic Circuit Facilitates Associative Learning
    Theodoros Tsetsenis, Julia K. Badyna, Rebecca Li, John A. Dani · 2022 · Frontiers in Cellular Neuroscience
  10. The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
    Daniele Caligiore, Flora Giocondo, Massimo Silvetti · 2022 · IBRO Neuroscience Reports
  11. Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers
    Jaeyoon Song, Eunseo Cho, Huiseop Lee, Suyoung Lee, Sehyeon Kim, Jinsik Kim · 2025 · Biosensors
  12. Divergence in the metabolome between natural aging and Alzheimer’s disease
    Holly C. Hunsberger, Bennett P. Greenwood, Vladimir Tolstikov, Niven R. Narain, Michael A. Kiebish, Christine Ann Denny · 2020 · Scientific Reports
  13. Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder
    Shôji Nakamura · 2022 · Frontiers in Bioscience-Scholar
  14. MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice.
    Li, Junhua, Li, Danhua, Zhou, Huatao, Wu, Guiyun, He, Zhijie, Liao, Wenhua, Li, Yujuan, Zhi, Yaowei · 2020 · Aging
  15. Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration
    Long Chen, Yuan Sun, Jinran Li, Sai Liu, Hancheng Ding, Guangji Wang, Xinuo Li · 2023 · Cells
  16. Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization
    QuanQiu Wang, Pamela B. Davis, Xin Qi, Shu G. Chen, Mark E. Gurney, George L. Perry, Pudugramam Murali Doraiswamy, Rong Xu · 2021 · Alzheimer s Research & Therapy
  17. Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer’s Diseases
    Han Yang, Haozhe Tan, Haifei Wen, Peikun Xin, Yanling Liu, Ziwei Deng, Yanning Xu, Feng Gao, Liping Zhang, Ziyue Ye et al. · 2024 · ACS Nano
  18. Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
    Seong Gak Jeon, Yong Jun Kim, Kyoung Ah Kim, Inhee Mook‐Jung, Minho Moon · 2018 · Molecular Neurobiology
  19. Reactive mesoporous silica nanoparticles loaded with limonene for improving physical and mental health of mice at simulated microgravity condition
    Zhiguo Lü, Jianze Wang, Lina Qu, Guanghan Kan, Tianlu Zhang, Jie Shen, Yan Li, Jun Yang, Yunwei Niu, Zuobing Xiao et al. · 2020 · Bioactive Materials
  20. Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward
    Rui Zhang, Peter Manza, Dardo G. Tomasi, Sung Won Kim, Ehsan Shokri Kojori, Şükrü Barış Demiral, Danielle S. Kroll, Dana E. Feldman, Katherine L. McPherson, Catherine L. Biesecker et al. · 2021 · Journal of Clinical Investigation
  21. Therapeutic effects of anodal transcranial direct current stimulation in a rat model of ADHD
    Da Hee Jung, Sung‐Min Ahn, Malk Eun Pak, Hong Ju Lee, Young–Jin Jung, Kibong Kim, Yong‐Il Shin, Hwa Kyoung Shin, Byung Tae Choi · 2020 · eLife
  22. Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment
    Laura Serra, Marcello D’Amelio, S Esposito, Carlotta Di Domenico, Giacomo Koch, Camillo Marra, Nicola Biagio Mercuri, Carlo Caltagirone, Carlo Alberto Artusi, Leonardo Lopiano et al. · 2021 · Journal of Alzheimer s Disease
  23. Heme Oxygenase-1 Activity as a Correlate to Exercise-Mediated Amelioration of Cognitive Decline and Neuropathological Alterations in an Aging Rat Model of Dementia
    Andrea Kurucz, Mariann Bombicz, Rita Kiss, Dániel Priksz, Balázs Varga, Tibor Hortobágyi, György Trencsényi, Renáta Szabó, Anikó Pósa, Rudolf Gesztelyi et al. · 2018 · BioMed Research International
  24. Epigenetic Blockade of Hippocampal SOD2 Via DNMT3b-Mediated DNA Methylation: Implications in Mild Traumatic Brain Injury-Induced Persistent Oxidative Damage
    Nagalakshmi Balasubramanian, Sneha Sagarkar, Amit G. Choudhary, Dadasaheb M. Kokare, Amul J. Sakharkar · 2020 · Molecular Neurobiology
  25. Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders
    Annalisa Nobili, Paraskevi Krashia, Alberto Cordella, Livia La Barbera, Maria Concetta Dell’Acqua, Angela Caruso, Annabella Pignataro, Ramona Marino, Francesca Sciarra, Filippo Biamonte et al. · 2018 · Molecular Neurobiology
  26. Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease
    Brooks, Lavida R. K., Mias, George I. · 2019 · Frontiers in Neuroscience
  27. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease
    Azizul Haque, Supriti Samantaray, Varduhi H. Knaryan, Mollie Capone, Azim Hossain, Denise D Matzelle, Raghavendar Chandran, Donald C. Shields, Ariana Q. Farrand, Heather A. Boger et al. · 2020 · Experimental Neurology
  28. Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets
    Omid Vakili, Pooria Asili, Zeinab Babaei, Maryam Mirahmad, Atoosa Keshavarzmotamed, Zatollah Asemi, Alireza Mafi · 2022 · CNS & Neurological Disorders - Drug Targets
  29. Entorhinal cortex–hippocampal circuit connectivity in health and disease
    Melissa Hernández‐Frausto, Carmen Vivar · 2024 · Frontiers in Human Neuroscience
  30. Cognitive synaptopathy: synaptic and dendritic spine dysfunction in age-related cognitive disorders
    Francisco José Barrantes · 2024 · Frontiers in Aging Neuroscience
  31. Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
    Sodiq Fakorede, Olubodun Michael Lateef, Wilson Amemewon Garuba, Priscilla Onaopemipo Akosile, Deborah Ave Okon, Abdullahi Tunde Aborode · 2025 · Journal of Alzheimer s Disease Reports
  32. Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition
    Madhavan Nampoothiri, Prasada Chowdari Gurram, Suman Manandhar, Sairaj Satarker, Jayesh Mudgal, Devinder S Arora · 2022 · CNS & Neurological Disorders - Drug Targets
  33. Lithium engages autophagy for neuroprotection and neuroplasticity: Translational evidence for therapy
    Stefano Puglisi‐Allegra, Gloria Lazzeri, Carla Letizia Busceti, Filippo Sean Giorgi, Francesca Biagioni, Francesco Fornai · 2023 · Neuroscience & Biobehavioral Reviews
  34. Beta-amyloid short- and long-term synaptic entanglement
    Lanni, Cristina, Fagiani, Francesca, Racchi, Marco, Preda, Stefania, Pascale, Alessia, Grilli, Massimo, Allegri, Nicola, Govoni, Stefano · 2019 · Pharmacological Research
  35. Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
    Mirjana Babić Leko, Patrick R. Hof, Goran Šimić · 2021 · Progress in brain research
  36. Benincasa hispida alleviates amyloid pathology by inhibition of Keap1/Nrf2-axis: Emphasis on oxidative and inflammatory stress involved in Alzheimer's disease model
    Deepthi Rapaka, Veera Raghavulu Bitra, Ravishankar Ummidi, Annapurna Akula · 2021 · Neuropeptides
  37. Disrupting Neurons and Glial Cells Oneness in the Brain—The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer’s Disease
    Matylda Barbara Mielcarska, Katarzyna Skowrońska, Zbigniew Wyżewski, Felix Ngosa Toka · 2021 · International Journal of Molecular Sciences
  38. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders
    Sarha A. L. Queiroz, Alyne Mendonça Marques Ton, Thiago de Melo Costa Pereira, Bianca Prandi Campagnaro, Larissa Martinelli, Aitor Picos, Manuel Campos‐Toimil, Elisardo C. Vasquez · 2022 · Frontiers in Psychiatry
  39. Aggregation of Ag nanoparticle based on surface acoustic wave for surface-enhanced Raman spectroscopy detection of dopamine
    Jin‐Oh Park, Yongheum Choi, Hyeong Min Ahn, Changki Lee, Honggu Chun, Young Min Park, Kwang Bok Kim · 2023 · Analytica Chimica Acta
  40. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation
    Stavros Skouras, Jordi Torner, Patrik U. Andersson, Yury Koush, Carles Falcón, Carolina Minguillón, Karine Fauria, Francesc Alpiste, Kaj Blenow, Henrik Zetterberg et al. · 2020 · Brain
  41. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
    Jean Albert Boutin, Frédéric Bouillaud, Elżbieta Janda, István Gacsályi, Gérald Guillaumet, Étienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis et al. · 2018 · Molecular Pharmacology
  42. Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease
    Max E Stevenson, Rency S. Varghese, Michaeline L. Hebron, Xiaoguang Liu, Nick Ratliff, Amelia Smith, Raymond Scott Turner, Charbel Moussa · 2023 · Journal of Neuroinflammation
  43. Correlating Selective Electrocatalysis of Dopamine and Ascorbic Acid Electrooxidation at Nanoporous Gold Surfaces with Structural-Defects
    Abhishek Kumar, Josué M. Gonçalves, Jéssica Soares da Silva · 2019 · Journal of The Electrochemical Society
  44. Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer’s disease
    Mao, Yimin, Fisher, Daniel W., Yang, Shuxing, Keszycki, Rachel M., Dong, Hongxin · 2020 · PLOS ONE
  45. Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
    Daniele Caligiore, Massimo Silvetti, Marcello D’Amelio, Stefano Puglisi‐Allegra, Gianluca Baldassarre · 2020 · Journal of Alzheimer s Disease
  46. Reduced monoaminergic nuclei MRI signal detectable in pre-symptomatic older adults with future memory decline
    Annalena Venneri, Matteo De Marco · 2020 · Scientific Reports
  47. Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model
    Elena Spoleti, Paraskevi Krashia, Livia La Barbera, Annalisa Nobili, Carmen Alina Lupaşcu, E. Giacalone, Flavio Keller, Michele Migliore, Massimiliano Renzi, Marcello D’Amelio · 2021 · Experimental Neurology
  48. Dopamine as a Potential Target for Learning and Memory: Contributing to Related Neurological Disorders
    Masoumeh Kourosh‐Arami, Alireza Komaki‬, Mohammad‐Reza Zarrindast · 2022 · CNS & Neurological Disorders - Drug Targets
  49. Chrysin-Loaded Chitosan Nanoparticle-Mediated Neuroprotection in Aβ 1–42 -Induced Neurodegenerative Conditions in Zebrafish
    Suraiya Saleem, Rachana Banerjee, Rajaretinam Rajesh Kannan · 2022 · ACS Chemical Neuroscience
  50. Nanoporous gold-based dopamine sensor with sensitivity boosted by interferant ascorbic acid
    Abhishek Kumar, Jéssica Soares da Silva, Josué M. Gonçalves · 2019 · Electrochimica Acta
  51. Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity
    Toshiko Ishikawa, Motoki Okano, Akiko Minami, Hiroko Tsunekawa, Hiroshi Satoyoshi, Yuka Tsukamoto, Kazue Takahata, Shizuko Muraoka · 2018 · Behavioural Brain Research
  52. Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344‐AD rat model of Alzheimer's disease
    Benjamin B. Tournier, Cristina Barca, Aïda B. Fall, Yesica Gloria, Léa Meyer, Kelly Ceyzériat, P. Millet · 2020 · Genes Brain & Behavior
  53. Effects of Vitamin E on the Gut Microbiome in Ageing and Its Relationship with Age-Related Diseases: A Review of the Current Literature
    Dashine Gothandapani, Suzana Makpol · 2023 · International Journal of Molecular Sciences
  54. Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
    Ammara Shaikh, Fairus Ahmad, S. Teoh, Jaya Kumar, Mohamad Fairuz Yahaya · 2023 · Frontiers in Cellular Neuroscience
  55. RETRACTED ARTICLE: MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor
    Jun Zhang, Zanchao Liu, Yuanyuan Pei, Wen K. Yang, Chicu Xie, Shiqi Long · 2018 · Neurochemical Research · Retracted
  56. Protective Effect of Chitosan Oligosaccharide against Hydrogen Peroxide-Mediated Oxidative Damage and Cell Apoptosis via Activating Nrf2/ARE Signaling Pathway
    Xiaoxia Zhang, Shuang Liang, Xiaohan Gao, Han‐Chang Huang, Fengxue Lao, Xueling Dai · 2021 · Neurotoxicity Research
  57. Ventral Tegmental Area in Prodromal Alzheimer’s Disease: Bridging the Gap between Mice and Humans
    Marcello D’Amelio, Laura Serra, Marco Bozzali · 2018 · Journal of Alzheimer s Disease
  58. Integration of Machine Learning Methods to Dissect Genetically Imputed Transcriptomic Profiles in Alzheimer’s Disease
    Carlo Maj, Tiago Azevedo, Valentina Giansanti, Oleg Borisov, Giovanna Maria Dimitri, Simeon Spasov, Alzheimer’s Disease Neuroimaging Initiative, Píetro Lió, Ivan Merelli · 2019 · Frontiers in Genetics
  59. Stabilized carbon coating on microelectrodes for scalable and interoperable neurotransmitter sensing
    Yongli Qi, Dongyeol Jang, Jaehyeon Ryu, Tianyu Bai, Yieljae Shin, Wen Gu, Aditya Iyer, Gen Li, Hongtao Ma, Jyun-you Liou et al. · 2025 · Nature Communications
  60. Pharmacology of Dopamine and Its Receptors
    Sunpreet Kaur, Shamsher Singh, Gagandeep Jaiswal, Sandeep Kumar, Wafa Hourani, Bapi Gorain, Puneet Kumar · 2020 · Springer eBooks
  61. Glucagon‐like peptide‐1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum‐induced dementia
    Nessren M. Abd el‐Rady, Amel Ahmed, Marwa Mahmoud Abdel‐Rady, Omnia I. Ismail · 2020 · Physiological Reports
  62. New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids
    Alessandra Gallo, Laure‐Elise Pillet, Romain Verpillot · 2021 · Experimental Gerontology
  63. Activation of TGR5 Ameliorates Streptozotocin‐Induced Cognitive Impairment by Modulating Apoptosis, Neurogenesis, and Neuronal Firing
    Rong-Hao Mu, Xian Guo Wu, Danhua Yuan, Jiajia Zhao, Susu Tang, Hao Hong, Yan Long · 2022 · Oxidative Medicine and Cellular Longevity
  64. Alteration of Neural Pathways and Its Implications in Alzheimer’s Disease
    Sujin Kim, Yunkwon Nam, Hyeon soo Kim, Haram Jung, Seong Gak Jeon, Sang Bum Hong, Minho Moon · 2022 · Biomedicines
  65. Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems
    Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, Wenrui Zhao, Peng Sun, Shichang Li, Lin Li · 2022 · Frontiers in Aging Neuroscience
  66. A multi‐omics analysis for the prediction of neurocognitive disorders risk among the elderly in Macao
    Yan Han, Xingping Quan, Yao Chen Chuang, Qiaoxing Liang, Yang Li, Zhen Yuan, Ying Bian, Lai Wei, Ji Wang, Yonghua Zhao · 2022 · Clinical and Translational Medicine
  67. Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
    Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, Md. Abubakar, Puneet Kumar, Thakur Gurjeet Singh, Randhir Singh · 2024 · Phytotherapy Research
  68. Amburana cearensis seed extract protects brain mitochondria from oxidative stress and cerebellar cells from excitotoxicity induced by glutamate
    Érica Patrícia Lima Pereira, Cleide Dos Santos Souza, Jéssika Alves Oliveira Amparo · 2017 · Journal of Ethnopharmacology
  69. Melatonin in Synaptic Impairments of Alzheimer’s Disease
    Yan Shi, Ying‐Yan Fang, Yuping Wei, Qian Jiang, Peng Hui Zeng, Na Tang, Youming Lu, Qing Tian · 2018 · Journal of Alzheimer s Disease
  70. Insulin sensing by astrocytes is critical for normal thermogenesis and body temperature regulation
    Iyad H. Manaserh, Emily F. Maly, Marziyeh Salehi Jahromi, Lakshmikanth L. Chikkamenahalli, Joshua C. Park, Jennifer Wootton Hill · 2020 · Journal of Endocrinology
  71. Ascorbate deficiency decreases dopamine release in gulo–/– and APP/PSEN1 mice
    David C. Consoli, Lillian J. Brady, Aaron B. Bowman, Erin S. Calipari, Fiona Edith Harrison · 2020 · Journal of Neurochemistry
  72. Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases
    Shasha Zhang, Fangyi Long, Hong Lin, Xi Wang, Gang Jiang, Ting Wang · 2021 · Pharmacological Research
  73. DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Waijiao Cai, Kazumasa Wakamatsu, Fabio Andrea Zucca, Qing Wang, Kai Yang, Niyaz Mohammadzadeh Honarvar, Pranay Srivastava, Hitomi Tanaka, Gabriel Holly, Luigi Casella et al. · 2023 · Progress in Neurobiology
  74. Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status
    Alfie R. Wearn, Stefanie A Tremblay, Christine Lucas Tardif, Ilana Ruth Leppert, Claudine Joëlle Gauthier, Giulia Baracchini, Colleen S. Hughes, Patrick Hewan, Jennifer Tremblay‐Mercier, Pedro Rosa‐Neto et al. · 2024 · Nature Communications
  75. Membrane Binding Strongly Affecting the Dopamine Reactivity Induced by Copper Prion and Copper/Amyloid-β (Aβ) Peptides. A Ternary Copper/Aβ/Prion Peptide Complex Stabilized and Solubilized in Sodium Dodecyl Sulfate Micelles
    Chiara Bacchella, Stefania Nicolis, Simone Dell’Acqua, Enrico Rizzarelli, Enrico Monzani, Luigi Casella · 2019 · Inorganic Chemistry
  76. Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
    Prajapati, Santosh Kumar, Pathak, Arjit, Samaiya, Puneet K. · 2024 · Metabolic Brain Disease
  77. Changes in neurotransmitter-related functional connectivity along the Alzheimer’s disease continuum
    Riccardo Manca, Matteo De Marco, Hilkka S. Soininen, Livia Ruffini, Annalena Venneri · 2024 · Brain Communications
  78. Ventral tegmental area disruption in Alzheimer’s disease
    Marco Bozzali, Marcello D’Amelio, Laura Serra · 2019 · Aging
  79. An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
    Serena Marcelli, Elena Ficulle, Laura Piccolo, Massimo Corbo, Marco Feligioni · 2017 · Pharmacological Research
  80. Gray matter volume covariance networks associated with social networks in older adults
    Helena M. Blumen, Joe Verghese · 2018 · Social Neuroscience
  81. Current Quest in Natural Bioactive Compounds for Alzheimers Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence
    Ashif Iqubal, Syed Obaidur Rahman, Musheer Ahmed, Pratichi Bansal, Md Rafi Haider, Mohammad Kashif Iqubal, Abul Kalam Najmi, Faheem Hyder Pottoo, Syed Ehtaishamul Haque · 2020 · Current Drug Targets
  82. The cognitive nuances of surprising events: exposure to unexpected stimuli elicits firing variations in neurons of the dorsal CA1 hippocampus
    Ornella Valenti, Nace Mikuš, Thomas Klausberger · 2018 · Brain Structure and Function
  83. Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease
    Marta Pérez-González, Sara Badesso, Elena Lorenzo, Elizabeth Guruceaga, Alberto Pérez‐Mediavilla, Ana García‐Osta, Mar Cuadrado‐Tejedor · 2021 · International Journal of Molecular Sciences
  84. Dysregulation of prefrontal parvalbumin interneurons leads to adult aggression induced by social isolation stress during adolescence
    Xinyang Li, Huan Sun, Yuanyuan Zhu, Feidi Wang, Xiaodan Wang, Lin Han, Dongqi Cui, Danlei Luo, Yifang Zhai, Lixia Zhuo et al. · 2022 · Frontiers in Molecular Neuroscience
  85. Structure, Function, and Molecular Landscapes of the Aging Retina
    Jeffrey D. Zhu, Sharma Pooja Tarachand, Qudrat Abdulwahab, Melanie A. Samuel · 2023 · Annual Review of Vision Science
  86. Prion Peptides Are Extremely Sensitive to Copper Induced Oxidative Stress
    Simone Dell’Acqua, Chiara Bacchella, Enrico Monzani, Stefania Nicolis, Giuseppe Di Natale, Enrico Rizzarelli, Luigi Casella · 2017 · Inorganic Chemistry
  87. Autophagy status as a gateway for stress-induced catecholamine interplay in neurodegeneration
    Francesco Fornai, Stefano Puglisi‐Allegra · 2021 · Neuroscience & Biobehavioral Reviews
  88. A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer’s disease
    Rouhi, Nadiyeh, Chakeri, Zahra, Ghorbani Nejad, Behnam, Rahimzadegan, Milad, Rafi Khezri, Mohammad, Kamali, Hossein, Nosrati, Rahim · 2024 · Heliyon
  89. Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease
    Ágoston Patthy, János Murai, János Hanics, Anna Pintér, Péter Zahola, Tomas G. M. Hökfelt, Tibor Harkany, Alán Alpár · 2021 · Journal of Clinical Medicine
  90. Neuroprotective Efficacy of Apple Cider Vinegar on Zinc-High Fat Diet-Induced Mono Amine Oxidase Alteration in Murine Model of AD
    Smriti Tripathi, Papiya Mitra Mazumder · 2021 · Journal of the American Nutrition Association
  91. Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline
    Clarissa Catale, Luisa Lo Iacono, Alessandro Martini, Constantin Heil, Ezia Guatteo, Nicola Biagio Mercuri, Maria Teresa Viscomi, Daniela Palacios, Valeria Carola · 2022 · Molecular Neurobiology
  92. Unlocking the secrets of dopamine in Alzheimer’s Disease
    Marcello D’Amelio, Robert Nisticò · 2017 · Pharmacological Research
  93. Astrocytic NLRP3 cKO mitigates depression-like behaviors induced by mild TBI in mice.
    Hui‐Tao Miao, Jun Wang, Jing-Jing Shao, Rong‐Xin Song, Wenguang Li, Jian-Kai Sun, Shi-Yan Jia, Dongxue Zhang, Xiaoming Li, Jianyong Zhao et al. · 2025 · Neurobiology of Disease
  94. Dopaminergic deficits along the spectrum of Alzheimer’s disease
    Andrea Pilotto, Alice Galli, Arianna Sala, Silvia Paola Caminiti, Luca Presotto, Claudio Liguori, Nicola Biagio Mercuri, Enrico Premi, Valentina Garibotto, Giovanni Battista Frisoni et al. · 2025 · Molecular Psychiatry
  95. Relationship between adult subventricular neurogenesis and Alzheimer’s disease: Pathologic roles and therapeutic implications
    Hyeon Soo Kim, Seong Min Shin, Sujin Kim, Yunkwon Nam, Anji Yoo, M. Moon · 2022 · Frontiers in Aging Neuroscience
  96. Changes of Protein Phosphorylation Are Associated with Synaptic Functions during the Early Stage of Alzheimer’s Disease
    Yuewen Chen, Jinying Xu, Xiaopu Zhou, Saijuan Liu, Yulin Zhang, Shuangshuang Ma, Amy K.Y. Fu, Nancy Y. Ip, Yu Chen · 2019 · ACS Chemical Neuroscience
  97. Efficacy and Safety of Psychostimulants for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Taro Kishi, Kenji Sakuma, Nakao Iwata · 2020 · Pharmacopsychiatry
  98. Kisspeptin preserves mitochondrial function by inducing mitophagy and autophagy in aging rat brain hippocampus and human neuronal cell line
    Ushodaya Mattam, Noble Kumar Talari, Arun Kumar Paripati, Thanuja Krishnamoorthy, Naresh Babu V. Sepuri · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  99. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson’s Disease
    Yoon-Sang Oh, Sang-Won Yoo, Chul Hyoung Lyoo, Ji-Yeon Yoo, Hyukjin Yoon, Seunggyun Ha, Kwang-Soo Lee, Joong-Seok Kim · 2021 · Journal of Parkinson s Disease
  100. Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
    Olaia A. Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, Lola Corzo, Ramón Cacabelos · 2022 · Pharmaceutics